創夢天地(01119.HK)擬不超2億港元回購股份 回購價不超每股5港元
格隆匯4月26日丨創夢天地(01119.HK)發佈公吿,董事會擬行使公司股東於公司於2021年6月25日舉行的股東周年大會上授予董事會購回公司股份的一般授權並在適當時購回場內股份。公司計劃以不高於港幣5元的價格進行股份購回,股份購回的總金額不超過港幣2億元。
董事會認為,場內交易股份的價值被嚴重低估,股份現時的成交價未能反映內在價值。公司目前的財務狀況和業務狀況良好,有充足的財務資源使公司有能力在進行股份回購計劃的同時維持集團業務快速發展。董事會相信,建議股份購回及於其後註銷所購回的股份可提升股份的價值,從而提高股東的回報。建議股份購回亦體現出董事會對公司的長遠業務前景及增長潛力充滿信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.